Lauer Wealth’s GSK GSK Stock Holding History

Lauer Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,534	Closed	-$337K	–	44
2023 Q4	$337K	Buy	8,534 +605	+8%	+$21.7K	0.31%	34
2023 Q3	$290K	Sell	7,929 -815	-9%	-$28.9K	0.31%	34
2023 Q2	$314K	Sell	8,744 -2,583	-23%	-$92.7K	0.32%	37
2023 Q1	$416K	Buy	+11,327	New	+$396K	0.52%	28

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lauer Wealth's GSK Position: Q1 2024 in Review

Lauer Wealth sold out of GSK (GSK) in Q1 2024, closing a stake of 8,534 shares — an estimated $337K sold.

Lauer Wealth first reported a position in GSK in Q1 2023 and held it in 4 quarters. The position peaked at $416K in Q1 2023. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

Lauer Wealth reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
Lauer Wealth sold 8,534 GSK shares in Q1 2024, an estimated $337K.
Lauer Wealth first reported a position in GSK in Q1 2023 and held it in 4 quarters.
Lauer Wealth's GSK position peaked at $416K in Q1 2023.
910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Lauer Wealth's 13F filing for Q1 2024, filed 16 Apr 2024.